LAS VEGAS, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC: GLXZ), the world’s largest independent developer and distributor of casino table games and technology, have entered into a ...
BBO-11818 is an orally bioavailable small molecule panKRAS dual ("ON" and "OFF" states) inhibitor that directly binds to KRAS with picomolar affinity BBO-11818 is expected to provide significant ...
The first patient has been dosed with BBO-11818 in the KONQUER-101 first-in-human clinical study BBO-11818 is an orally bioavailable small molecule panKRAS dual (“ON” and “OFF” states) inhibitor that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results